Welcome to our dedicated page for GENWORTH FINANCIAL SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GENWORTH FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GENWORTH FINANCIAL's regulatory disclosures and financial reporting.
Genworth Financial director Steven C. Van Wyk received an equity grant as part of his board compensation. He was awarded 32,100 restricted stock units (RSUs) of Genworth Financial common stock, valued using a twenty-day average trading price of $9.0345 per share. These RSUs represent a portion of his annual retainer fee, vest on the one-year anniversary of the grant date, and convert into common shares at vesting unless he has elected to defer receipt. Following this grant, Van Wyk directly holds 77,675.883 shares of Genworth common stock.
GENWORTH FINANCIAL INC director Ramsey D. Smith received an equity grant of 18,264 shares of Common Stock as part of his annual retainer. The award is in the form of restricted stock units that vest on the one-year anniversary of the grant date and then convert into shares, unless he has elected to defer receipt. The grant was sized using a twenty-day average trading price of about $9.03 per share. Following this compensation-related award, he directly holds 92,655.011 shares.
Genworth Financial director Elaine A. Sarsynski received a grant of 32,100 restricted stock units (RSUs) as payment for a portion of her annual board retainer. The RSUs were sized using a twenty-day average Genworth common stock price of $9.0345 per share.
The RSUs vest on the one-year anniversary of the grant date and then convert into shares of common stock, unless she elected to defer receipt until leaving the board or a future specified year. After this award, she directly holds a total of 164,999.154 shares reported as common stock-related holdings.
Genworth Financial director Robert P. Restrepo Jr. received a grant of 18,264 restricted stock units as part of his annual retainer fee. The RSUs vest on the one-year anniversary of the grant and then convert into common shares, unless he elected to defer delivery.
GENWORTH FINANCIAL INC director Howard D. Mills III received an equity grant of 18,264 shares of Common Stock as part of his annual retainer. The grant reflects restricted stock units (RSUs) that were valued using a twenty-day average trading price of $9.0345 per share.
The RSUs vest on the one-year anniversary of the grant date and convert into shares of Common Stock at vesting, unless Mills elects to defer receipt until his board service ends or to a future specified year. Following this grant, he holds 92,655.011 shares directly.
GENWORTH FINANCIAL INC director Melina E. Higgins received an equity grant as part of her board compensation. She was awarded 31,547 restricted stock units of Common Stock at a reference price of $9.0345 per share, based on the twenty-day average trading price.
The RSUs were granted in payment of a portion of her annual retainer fee. They vest on the one-year anniversary of the grant date and then convert into shares of Common Stock, unless she has elected to defer receipt until leaving the board or a future specified year. After this grant, her direct holdings total 163,728.537 shares of Common Stock.
GENWORTH FINANCIAL INC director Jill R. Goodman received an equity grant of 18,264 shares of Common Stock via restricted stock units. The RSUs were granted as part of her annual retainer fee at an implied price of $9.0345 per share, based on the twenty-day average trading price. These RSUs vest on the one-year anniversary of the grant date and convert into common shares upon vesting, unless she has elected to defer receipt. After this award, Goodman directly holds a total of 92,655.011 shares of Genworth common stock.
Genworth Financial director Karen Elizabeth Dyson received an equity grant as part of her board compensation. She was awarded 18,264 shares of Common Stock in the form of restricted stock units, valued using a twenty-day average trading price of $9.0345 per share.
The RSUs were granted as payment for a portion of her annual retainer fee and will vest on the one-year anniversary of the grant date. Upon vesting, they convert into shares of Common Stock, unless she has elected to defer receipt until leaving the board or to a future year. After this award, she directly holds 92,655.011 shares.
GENWORTH FINANCIAL INC director Conrad G. Kent received an equity compensation grant rather than making an open-market trade. He was awarded 18,264 restricted stock units (RSUs) as part of his annual retainer fee, valued using a $9.0345 twenty-day average trading price per share of Common Stock.
The RSUs vest on the one-year anniversary of the grant date and then convert into shares of Common Stock, unless he has elected to defer receipt until leaving the board or a future specified year. After this award, he directly holds 92,655.011 shares of Common Stock.
Genworth Financial, Inc. reported the results of its 2026 annual stockholders meeting held on May 20, 2026. Shareholders elected all ten director nominees, with votes for individual directors ranging from 300,269,224 to 306,779,465 and broker non-votes of 30,908,201 for each nominee.
Stockholders also approved, on an advisory basis, compensation for named executive officers with 303,193,071 votes for and 10,747,307 against. They approved the 2026 Genworth Financial, Inc. Associate Stock Purchase Plan with 307,109,681 votes for, and ratified the selection of KPMG LLP as independent registered public accounting firm for 2026 with 333,181,180 votes for.